Momenta, Sandoz Can't Beat Blood Clot Drug Monopoly Suit
By Dani Kass ( September 30, 2016, 7:59 PM EDT) -- A Tennessee federal magistrate judge on Thursday recommended that a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring to monopolize the market for a generic of the blood clot drug Lovenox should stand, as a hospital sufficiently alleged that the companies manipulated the organization that sets quality testing standards....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.